Ruthenium Global Pharma Fund tops the BarclayHedge Health Care/Biotech Ranking
According to the BarclayHedge platform, Ruthenium Global Pharma Fund showed the highest result in the Health Care/Biotech sector in September. LUXEMBOURG, December 5, 2022 /EINPresswire.com/ -- According to the BarclayHedge platform, which monitors the …